About us

Our vision

Our vision is to offer better protection to patients during acute, severe and life-threatening medical conditions by an effective, user-friendly, safe and immediately active powder-based Intranasal specialized products.

Management

Dan Teleman, CEO

Chief Executive Officer

Dr. Dalia Megiddo

Co-founder, Board Member & Chief Development Officer

Tair Lapidot, Ph.D

VP R&D AND CLINICAL DEVELOPMENT

Galia Temtsin Kryaz, Ph.D.

Director of Product Development

Oren Elmaliah

DIrector of Finance

Board of Directors

Udi Gilboa

Co-Founder & Executive Chairman

Dr. Dalia Megiddo

Co-founder, Board Member & Chief Development Officer

Dr. Ronnie Hershman

Board Member

Team Members

Galia Temtsin Kryaz, Ph.D.

Director of Product Development

Tair Lapidot, Ph.D

VP R&D and Clinical Development

Carolina Abrutzky

VP CMC

Oren Elmaliah

Director of Finance

Iris Erez

Commercial & Marketing Director

MIQUEL MARTI JUVANTENY

Director of Business Development

Ayelet Rahav

Senior Director of RA & QA

Advisory Board

Prof Yuval Tal

Prof Regina Scherließ

David M. Fleischer, MD

Jonathan Bernstein, MD

Our story

Nasus pharma brings the new frontier in Intranasal drug delivery. Late-Stage Specialty Pharma company, offers Powder-Based Intranasal (PBI) specialized product portfolio, to address acute medical conditions and public health threats.